Synergistic Enhancement of Antitumor Effects by Combining Abemaciclib With Desipramine
Yan Li(North Sichuan Medical University), Sung‐Ho Goh(National Cancer Center)
Cited by 1
Related Papers
CD44v8-10 as a potential theranostic biomarker for targeting disseminated cancer cells in advanced gastric cancer
|Scientific Reports|2017|25
<p>The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer</p>
|OncoTargets and Therapy|2019|13
ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί
|International Journal of Molecular Sciences|2021|9
Synergistic Enhancement of Antitumor Effects by Combining Abemaciclib with Desipramine
|International Journal of Molecular Sciences|2024|2